Medical Innovation Zebrowski sp. k. (Poland)

Main Activities: Department Stores

Secondary Activities: Pharmaceutical Preparation Manufacturing | Miscellaneous Durable Goods Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses | Warehousing and Storage | Electronic and Precision Equipment Repair and Maintenance | Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance

Full name: Medical Innovation Zebrowski sp. k.

Profile Updated: June 10, 2024

Medical Innovation Zebrowski sp. k. is based in Poland, with the head office in Radomsko. The company operates in the Department Stores industry. It was incorporated on April 14, 2023. The latest financial highlights indicate a net sales revenue increase of 1385.44% in 2025. Its total assets grew by 173.31% over the same period.

Headquarters
Ul. Kolejowa 8B
Radomsko; Lodzkie; Postal Code: 97-500

Contact Details: Purchase the Medical Innovation Zebrowski sp. k. report to view the information.

Basic Information

Financial Auditors:

Purchase the Medical Innovation Zebrowski sp. k. report to view the information.

Incorporation Date:

April 14, 2023

Key Executives

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Medical Innovation Zebrowski sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

1385.44%▲

Total Operating Revenue

1305.54%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

173.31%▲

Total Equity

2873.41%▲

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Similar companies